Former FTC Chair Highlights Dangers of Private Equity in U.S. Healthcare

January 27, 2025 - 07:07

The former head of the Federal Trade Commission has raised alarms about the detrimental effects of private equity firms on the U.S. healthcare system. According to the ex-chair, these firms are increasingly influencing healthcare practices in ways that could lead to serious consequences for American patients. The concerns revolve around the prioritization of profits over patient care, which can result in reduced access to essential services and inflated costs.

The ex-chair emphasized that the current trajectory could lead to a “catastrophic” situation for many Americans who rely on the healthcare system. She urged the White House to take a closer look at the role private equity plays in healthcare, suggesting that regulatory measures may be necessary to protect patients and ensure equitable access to care.

As private equity continues to invest heavily in healthcare sectors, the implications for quality, affordability, and accessibility remain a pressing issue that demands immediate attention from policymakers. The call for action reflects a growing recognition of the need to safeguard the integrity of the healthcare system amidst evolving financial interests.